Search This Blog

Thursday, February 6, 2020

Enanta Pharma EPS beats by $0.09, misses on revenue

Enanta Pharma (NASDAQ:ENTA): Q1 GAAP EPS of $0.65 beats by $0.09.
Revenue of $52.57M (-24.8% Y/Y) misses by $6.18M.
Press Release
https://seekingalpha.com/news/3539396-enanta-pharma-eps-beats-0_09-misses-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)